Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Frontiers in Oncology
|
August 1, 2022
Apoptotic and Necroptotic Mediators are Differentially Expressed in Mucinous and Non-Mucinous Colorectal Cancer
Emer O'Connell, Ian S Reynolds, Andreas U Lindner, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
May 12, 2023
Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome
William P Duggan, Manuela Salvucci, Batuhan Kisakol, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
December 19, 2019
Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea
Andreas U Lindner, Alexa J Resler, Steven Carberry, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
High-Resolution Spatial Proteomics Characterises Colorectal Cancer Consensus Molecular Subtypes
Batuhan Kisakol, Anna Sturrock, Sanghee Cho, et al.
Frontiers in Pharmacology
|
January 23, 2024
Anti-seizure effects of JNJ-54175446 in the intra-amygdala kainic acid model of drug-resistant temporal lobe epilepsy in mice
Omar Mamad, Mona Heiland, Andreas U Lindner, et al.
Cancer Research
|
January 19, 2013
Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy
Andreas U Lindner, Caoimhín G Concannon, Gerhardt J Boukes, et al.
Molecular Cancer Therapeutics
|
October 24, 2022
Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer
Hajrah Khawaja, Rebecca Briggs, Cheryl H Latimer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 4, 2021
Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populations
Xanthi Stachtea, Maurice B Loughrey, Manuela Salvucci, et al.
Cancers
|
October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
Alice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Gut
|
September 25, 2016
BCL-2 system analysis identifies high-risk colorectal cancer patients
Andreas U Lindner, Manuela Salvucci, Clare Morgan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Frontiers in Oncology
|
August 1, 2022
Apoptotic and Necroptotic Mediators are Differentially Expressed in Mucinous and Non-Mucinous Colorectal Cancer
Emer O'Connell, Ian S Reynolds, Andreas U Lindner, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
May 12, 2023
Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome
William P Duggan, Manuela Salvucci, Batuhan Kisakol, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
December 19, 2019
Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea
Andreas U Lindner, Alexa J Resler, Steven Carberry, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
High-Resolution Spatial Proteomics Characterises Colorectal Cancer Consensus Molecular Subtypes
Batuhan Kisakol, Anna Sturrock, Sanghee Cho, et al.
Frontiers in Pharmacology
|
January 23, 2024
Anti-seizure effects of JNJ-54175446 in the intra-amygdala kainic acid model of drug-resistant temporal lobe epilepsy in mice
Omar Mamad, Mona Heiland, Andreas U Lindner, et al.
Cancer Research
|
January 19, 2013
Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy
Andreas U Lindner, Caoimhín G Concannon, Gerhardt J Boukes, et al.
Molecular Cancer Therapeutics
|
October 24, 2022
Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer
Hajrah Khawaja, Rebecca Briggs, Cheryl H Latimer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 4, 2021
Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populations
Xanthi Stachtea, Maurice B Loughrey, Manuela Salvucci, et al.
Cancers
|
October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
Alice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Gut
|
September 25, 2016
BCL-2 system analysis identifies high-risk colorectal cancer patients
Andreas U Lindner, Manuela Salvucci, Clare Morgan, et al.
Page
of 6